Semi-Quantitative Analysis of Post-Transarterial Radioembolization Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With Tc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT)

Objectives: The purpose of this study is to evaluate the correlation between pretreatment planning technetium-99m (Tc) macroaggregated albumin (MAA) SPECT images and posttreatment transarterial radioembolization (TARE) yttirum-90 (Y) PET/CT images by comparing the ratios of tumor-to-normal liver counts. Methods: Fifty-two patients with advanced hepatic malignancy who underwent Y microsphere radioembolization from January 2010 to December 2012 were retrospectively reviewed. Patients had undergone Tc MAA intraarterial injection SPECT for a pretreatment evaluation of microsphere distribution and therapy planning. After the administration of Y microspheres, the patients underwent posttreatment Y PET/CT within 24 h. For semiquantitative analysis, the tumor-to-normal uptake ratios in Y PET/CT (TNR-yp) and Tc MAA SPECT (TNR-ms) as well as the tumor volumes measured in angiographic CT were obtained and analyzed. The relationship of TNR-yp and TNR-ms was evaluated by Spearman's rank correlation and Wilcoxon's matched pairs test. Results: In a total of 79 lesions of 52 patients, the distribution of microspheres was well demonstrated in both the SPECT and PET/CT images. A good correlation was observed of between TNR-ms and TNR-yp (rho value = 0.648, p < 0.001). The TNR-yp (median 2.78, interquartile range 2.43) tend to show significantly higher values than TNR-ms (median 2.49, interquartile range of 1.55) ( p = 0.012). The TNR-yp showed weak correlation with tumor volume (rho = 0.230, p = 0.041). Conclusions: The Tc MAA SPECT showed a good correlation with Y PET/CT in TNR values, suggesting that Tc MAA can be used as an adequate pretreatment evaluation method. However, the Tc MAA SPECT image consistently shows lower TNR values compared to Y PET/CT, which means the possibility of underestimation of tumorous uptake in the partition dosimetry model using Tc MAA SPECT. Considering that Tc MAA is the only clinically available surrogate marker for distribution of microsphere, we recommend measurement of tumorous uptake using Y PET/CT should be included routinely in the posttherapeutic evaluation. [ABSTRACT FROM AUTHOR]